The Title of the Video Would Go Here

Press Release:

Ochsner Medical Center Implants
1st Total Artificial Heart in Gulf South Region*

Bedridden for Months, 41-Year-Old Father of Five Was Walking Again Two Weeks after Implant

 

May 7, 2013: Alfred Williams, the first patient in the Gulf South Region to receive the SynCardia Total Artificial Heart, with his mother Rebecca Williams at Ochsner Medical Center in New Orleans.May 7, 2013: Alfred Williams, the first patient in the Gulf South Region to receive the SynCardia Total Artificial Heart, with his mother Rebecca Williams at Ochsner Medical Center in New Orleans.

TUCSON, Ariz. – May 9, 2013 – When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left... until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart.

"This device serves as a bridge to transplant which would buy him the time he needs to rehabilitate while waiting on an organ transplant," said Dr. Hector Ventura, Section Head of Heart Failure and Transplantation at Ochsner Medical Center.

To save Mr. Williams' life, on Feb. 21, the Ochsner medical team, led by Dr. Aditya Bansal, performed the first implant of the SynCardia Total Artificial Heart in the Gulf South Region*. Within two weeks of the surgery, Mr. Williams was out of bed and walking again. He has since been moved out of the ICU and is taking twice daily walks around the hospital.

"This is a guy who didn't walk for three months before his implantation," said Dr. Bansal. "Now he is walking all over
the hospital. It is a feeling of satisfaction and that as a group, we've made a difference – we've changed his life."

An experienced truck driver, Mr. Williams was diagnosed with heart problems after getting a “funny feeling” and having trouble breathing while driving one day. He immediately pulled over and dialed 911. By the time help arrived, he was seizing and receiving limited oxygen to his brain.

“If it wasn’t for the Ochsner team, I probably wouldn’t have made it,” said Mr. Williams. “They took care of me and I’m determined to get better. I have to show them love because they helped me through this fight. I thank each and every one of them who was a part of this.”

Today, Mr. Williams is on the transplant list waiting for a matching donor heart and kidney. With his new outlook on life, he has one goal in mind – to attend the high school graduation of his youngest daughter later this month, who plans to go to nursing school.

View news coverage of Ochsner’s first implant
Read press release from Ochsner Medical Center

*Ochsner defines the Gulf South Region as the area extending from Louisiana to the Florida Panhandle.

###

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end stage heart failure affecting both sides of the heart (biventricular failure). There have been nearly 1,300 implants of the Total Artificial Heart, accounting for more than 350 patient years of life on the device.

Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves. It is the only device that eliminates the symptoms and source of end stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at 97 SynCardia Certified Centers worldwide with 39 others in the process of certification.

The Total Artificial Heart provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

For up-to-date information, please visit: http://www.syncardia.com
Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn

 

Media Contact:
Don Isaacs
Vice President of Communications
SynCardia Systems, Inc.
Cell: (520) 955-0660

 

 

*The SynCardia temporary Total Artificial Heart was formerly known as the
SynCardia temporary CardioWest™ Total Artificial Heart.

FREE News Sign-Up

3538727_sBe Among the First to
Receive SynCardia News

... right in your email box